UK Supreme Court Bolsters Enforcement of ICSID Awards, Rejecting Sovereign Immunity Claims

The United Kingdom’s Supreme Court has delivered a significant ruling reinforcing the enforceability of awards issued by the International Centre for Settlement of Investment Disputes (ICSID). In a unanimous decision on March 4, 2026, the Court confirmed that states party to the ICSID Convention cannot invoke sovereign immunity to resist the recognition of ICSID awards against them within the UK legal system. This ruling clarifies a key aspect of international investment law and provides greater certainty for investors seeking recourse through ICSID arbitration.

Signatories to the ICSID Convention Have Waived Sovereign Immunity in UK Courts

The case, The Kingdom of Spain v Infrastructure Services Luxembourg S.À.R.L. And another; Republic of Zimbabwe v Border Timbers Ltd and another [2026] UKSC 9, involved appeals from a 2024 Court of Appeal decision. Both Spain and Zimbabwe argued they were entitled to immunity from enforcement in the UK since they had not explicitly submitted to the jurisdiction of UK courts. However, the Supreme Court disagreed, citing the terms of the ICSID Convention.

Under Section 1(1) of the State Immunity Act 1978, states generally enjoy immunity from the jurisdiction of UK courts unless they have waived that immunity. Section 2(2) of the Act allows a state to submit to jurisdiction either through a prior written agreement or after a dispute arises. The Court found that by ratifying the ICSID Convention, Spain and Zimbabwe had submitted to the jurisdiction of UK courts for the specific purpose of recognizing ICSID awards.

Article 54(1) of the ICSID Convention obligates Contracting States to “recognize an award rendered pursuant to this Convention as binding and enforce the pecuniary obligations imposed by that award within its territories as if it were a final judgment of a court in that State.” The Supreme Court interpreted this provision as creating a reciprocal commitment: states agree to enforce ICSID awards in their own courts, and, waive their sovereign immunity when facing adverse ICSID awards in other Contracting States’ courts.

The Court rejected arguments that Article 54(1) did not constitute a clear and unequivocal waiver of immunity, finding that a waiver can be implied from the terms of an agreement and their inherent consequences.

Supreme Court Declines to Rule on the “Arbitration Exception” to Immunity

A secondary issue before the Court concerned Section 9(1) of the State Immunity Act, which provides that a state may waive immunity through a written arbitration agreement. Spain argued that the arbitration agreement in its case was invalid due to conflict with EU law.

However, the Supreme Court declined to rule on this point, given its decision regarding Section 2(2) of the Act. The question of whether arbitrating a dispute constitutes a waiver of immunity remains open for future consideration.

Implications for International Arbitration

This ruling is a significant win for investors and strengthens London’s position as a leading center for international arbitration. By confirming that ICSID awards can be registered and enforced against states that are parties to the Convention, the UK Supreme Court has removed a potentially significant obstacle to enforcement. The decision does not affect a State’s immunity from execution against its assets.